GIS:FRA
Gilead Sciences, Inc
€136.10
arrow_upward
+1.57%(+2.10) 1D
Okt 14, 10:00:00 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa GIS...
Buksan
€131.56
Mataas
€136.10
Mababa
€131.56
Mkt. cap
190.38B
Avg. na dami
423.00
Dami
250.00
Mataas nang 52-wk
€136.10
Mababa nang 52-wk
€97.79
Bilang ng mga empleyado
17K
Buksan
€131.56
Mataas
€136.10
Mababa
€131.56
Mkt. cap
190.38B
Avg. na dami
423.00
Dami
250.00
Mataas nang 52-wk
€136.10
Mababa nang 52-wk
€97.79
Bilang ng mga empleyado
17K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Kalkine Media
·
49 minuto ang nakalipas
Gilead Sciences (NASDAQ:GILD): What Changes After Its Latest Company Update?
MarketBeat
·
1 oras ang nakalipas
Gilead Sciences (NASDAQ:GILD) Stock Price Up 3.9% - What's Next?
StocksToTrade
·
2 oras ang nakalipas
Gilead Sciences Stock Draws Wave Of Bullish Target Hikes
TradingKey
·
4 oras ang nakalipas
Gilead Sciences Inc Stock (GILD) Moved Up by 3.12% on Oct 14: Facts Behind the Movement
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
Tungkol sa Gilead Sciences, Inc
CEODaniel O'Day
Mga Empleyado17K
ItinatagHun 22, 1987
HeadquartersFoster City, California, Estados Unidos
Sektor-
Websitegilead.com